#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cerebral amyloid angiopathy Porphyria non-acute Neoplasm Hepatic angiosarcoma Peripheral primitive neuroectodermal tumour of soft tissue Burkitt's lymphoma Neuroendocrine tumour of the lung Hypereosinophilic syndrome Breast cancer Leukocyte adhesion deficiency type I Juvenile psoriatic arthritis Lung adenocarcinoma B-cell lymphoma refractory Enteritis Chronic graft versus host disease in skin More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma stage IV – Treatment Ocular melanoma – Life with Disease Waldenstrom’s macroglobulinaemia refractory Cystic fibrosis Epidermolysis bullosa – Basic Information Urea cycle disorder – Diagnostics Glomerulonephritis membranous Friedreich’s ataxia – Life with Disease Sarcoidosis – Diagnostics Anaplastic thyroid cancer More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Procarbazine Carcik-Cd19 Cells Mirabegron RUBIDIUM CHLORIDE Seralutinib Nizatidine Levamisole Hydrochloride Gindameran Perflutren Levocarnitine Lavender Oil Mps-214 Bepirovirsen Pyridoxine Hydrochloride Camizestrant Volixibat Rbl012.2 Epinephrine Hydrochloride Adagrasib Candesartan Cilexetil More therapies…

    Learn about Your Condition

    Angiosarcoma metastatic Dementia with Lewy bodies Breast cancer metastatic Ovarian cancer stage IV Benign renal neoplasm Magnetic resonance imaging Follicular lymphoma stage IV Premature rupture of membranes Hypersomnia Interstitial lung disease Psoriasis Craniopharyngioma Tuberculosis Lipid metabolism disorder Meniere's disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Helse Fonna HF

Helse Fonna HF

Karmsundgata 120, Haugesund, 5528, Norway

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Sotorasib for Patients with Advanced KRAS G12C-Mutated Non-Small Cell Lung Cancer and Comorbidities

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Sotorasib
    Denmark Norway Sweden
  • Study on the Safety of Tenofovir Alafenamide and Natalizumab for People with Multiple Sclerosis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Multiple sclerosis
    Investigated Drugs:
    • Natalizumab
    • Tenofovir Alafenamide
    Norway
  • Study on the Effect of Adding Thoracic Radiotherapy to Durvalumab and Chemotherapy for Patients with Extensive Stage Small-Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Small cell lung cancer extensive stage
    Investigated Drugs:
    • Durvalumab
    Estonia Iceland The Netherlands Norway Sweden
Previous Page
1 2

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!